Skip to main content

Closed

GYRE: Gyre Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Mixed

Operating margin-0.1%

ROIC0.4%

Financially safe

Stretched

Debt / equity0.01×

Interest coverage0.0×

Current ratio4.64×

Gyre Therapeutics, Inc.

GYRENASDAQ Capital Market·USD·Closed

Gyre Therapeutics, Inc.

GYRENASDAQ·USD·Closed

$5.75

−1.03%

$5.75

−$0.06 (1.03%)

52W Range

8thpctl

Volume

0.51×avg

Mkt Cap

525.50MUSD

P/E

-78.6TTM

Div Yield

–ann

52W Range

8thpctl

Volume

0.51×avg

Market Cap

525.50MUSD

P/E Ratio

-78.6TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings